GL1X · GenesisL1 explorer

MolNFT v1 · #109202 · protein

An engineered PYR1 mandipropamid receptor in complex with mandipropamid and HAB1

4WVO · Abscisic acid receptor PYR1: “An engineered PYR1 mandipropamid receptor in complex with mandipropamid and HAB1”. X-ray diffraction, 2 ligands (3UZ, MG), 4 pockets (best druggability 0.86). MolNFT v1 #109202 on GenesisL1: 3D…

PDB
4WVO
Type
protein
Length
470 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Abscisic acid receptor PYR1; Protein phosphatase 2C 16
EC
3.1.3.16
UniProt
O49686, Q9CAJ0
Ligands
3UZ, MG
Pockets
4 · best druggability 0.86

Structure

x-ray diffraction · 2 distinct chains · 31% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAbscisic acid receptor PYR1protein17430% helix, 39% strandO49686
BProtein phosphatase 2C 16 (EC 3.1.3.16)protein29632% helix, 30% strandQ9CAJ0

Ligands and binding sites

  • 3UZ · (2S)-2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)ethanamide · ligand · chains A, B
  • MG · Magnesium ion · metal · 3 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13310.860.96453UZ
22630.550.7732MG
3670.320.7510empty
4660.290.7317empty

Interfaces

1 interface between chains.

  • A–B · 871 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • Q9CAJ0 · AlphaFold monomer V2.0 prediction for protein phosphatase 2C 16 (Q9CAJ0) · a predicted model of the same protein · chain B against A, TM-score 0.99
  • O49686 · AlphaFold monomer V2.0 prediction for abscisic acid receptor PYR1 (O49686) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.